Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02929810 · ClinicalTrials.gov registry record · NA

Sleep Extension and Blood Pressure

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
9
Enrollment target

NCT02929810: Completed NA study, sponsored by Mayo Clinic.

NCT02929810 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02929810, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

Emerging evidence suggests that approximately 30% of the US adult population sleeps less than 7 hours per night, and those who do exhibit 20-52% enhanced risk to develop cardiovascular diseases and particularly hypertension. Since sleep curtailment is largely voluntary, sleep deficiency can be corrected and its detrimental health consequences potentially reversed. The purpose of the present proposal is to investigate the cardiovascular and metabolic effects of sleep extension in prehypertensive and stage 1 hypertensive subjects who report habitual short sleep.

Interventions

  • BEHAVIORAL sleep extension
  • BEHAVIORAL sleep maintenance

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2016-10
Est. Completion 2023-09-07
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT02929810

The ClinicalTrials.gov registry entry for NCT02929810 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which sleep extension is the first listed.

NCT02929810 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02929810 about?

NCT02929810 is a clinical study titled "Sleep Extension and Blood Pressure". Emerging evidence suggests that approximately 30% of the US adult population sleeps less than 7 hours per night, and those who do exhibit 20-52% enhanced risk to develop cardiovascular diseases and particularly hypertension. Since sleep curtailment is largely voluntary, sleep deficiency can be corre...

What is the current status of trial NCT02929810?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2016-10. Estimated completion is 2023-09-07.

What interventions are being tested in trial NCT02929810?

The interventions under investigation include: sleep extension (BEHAVIORAL), sleep maintenance (BEHAVIORAL).

Who is sponsoring clinical trial NCT02929810?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.